GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Land And Improvements

Cytophage Technologies (TSXV:CYTO) Land And Improvements : C$0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Land And Improvements?

Cytophage Technologies's land and improvements for the quarter that ended in Mar. 2024 was C$0.00 Mil.


Cytophage Technologies Land And Improvements Historical Data

The historical data trend for Cytophage Technologies's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Land And Improvements Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23
Land And Improvements
- - -

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Land And Improvements Get a 7-Day Free Trial - - - - -

Cytophage Technologies Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


Cytophage Technologies (TSXV:CYTO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.

Cytophage Technologies (TSXV:CYTO) Headlines

From GuruFocus

Altamira Therapeutics Provides Update on Clinical Trials with Bentrio

By Stock market mentor Stock market mentor 01-24-2023

Altamira Therapeutics Provides Business Update

By Stock market mentor Stock market mentor 01-27-2023